Boris Kubuschok und Preuss - Info zur Person

(1 - 13 von 17

)

Bewarder CV - José-Carreras-Center Homburg

www.carreras-center.de

Moritz Bewarder, Boris Kubuschok, Klaus-Dieter Preuss, Claudia Schormann, Michael Pfreundschuh, and Frank Neumann ASH 2016: CD3/BARs: A Novel Bispecific Format for the Treatment of B-cell Lymphomas. Moritz Bewarder, Lorenz Thurner, Natalie Fadle, Maria Kemele, Evi Regitz, Klaus-Dieter Preuss and Michael Pfreundschuh DGHO 2017:

Publikationen der UdS: Prospective study on the expression of cancer...

publikationen.sulb.uni-saarland.de

Prospective study on the expression of cancer testis genes and antibody responses ... Axel Mischo 1, Boris Kubuschok , Kubilay Ertan2, Klaus-Dieter Preuss , ...

B‐cell receptors of EBV‐negative Burkitt lymphoma bind OPUS 4

opus.bibliothek.uni-augsburg.de

... Michael Pfreundschuh, Hans G. Drexler, Markus Hoth, Boris Kubuschok, Klaus Roemer, Klaus‐Dieter Preuss, Sylvia Hartmann, Lorenz Thurner ... › index › docId

652. Myeloma: Pathophysiology and Pre-Clinical Studies ...

ash.confex.com

von GL Moore · · Zitiert von: 23 — Frank Neumann, PhD*, Boris Kubuschok, MD, Klaus-Dieter Preuss, PhD*, Claudia Schormann* and Michael Pfreundschuh, MD. › ash › Sess...

Analysis of the antibody repertoire of patients with mantle cell...

hal.archives-ouvertes.fr

Carsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, Gerhard Held, Manfred Ahlgrimm, et al.. Analysis of the antibody repertoire of patients with mantle cell ...

Management of diffuse large B-cell lymphoma (DLBCL)

pubmed.ncbi.nlm.nih.gov

von B Kubuschok · · Zitiert von: 69 — Authors. Boris Kubuschok , Gerhard Held, Michael Pfreundschuh. Affiliation. 1 German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL), ... von KD Preuss · · Zitiert von: 31 — Klaus-Dieter Preuss, Michael Pfreundschuh, Martin Weigert, Natalie Fadle, Evi Regitz, Boris Kubuschok. PMID: ; PMCID: PMC › ...